LungLife AI Company Description

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.

The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan.

The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019.

LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.

LungLife AI, Inc.

Country	United States
Founded	2009
Industry	Medical - Diagnostics & Research
Sector	Healthcare
Employees	15
CEO	Paul Pagano

Contact Details

Address: 2545 West Hillcrest Drive Thousand Oaks, Delaware 91320 United States
Phone	805 409 9868
Website	lunglifeai.com

Stock Details

Ticker Symbol	LLAI
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	USU5500L1045
SIC Code	2835

Key Executives

Name	Position
Paul Pagano	Chief Executive Officer
David Anderson	Chief Financial Officer